Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: New Glaxo / Merck antidepressant

Posted by SLS on March 3, 2002, at 19:33:15

In reply to Re: Duloxetine » Bob, posted by SLS on March 3, 2002, at 12:54:07

Here's a new one (sort of):

http://pharmalicensing.com/news/adisp/982274821_3a8c5305199e4

Excerpts:

"GlaxoSmithKline plc and Merck KGaA have signed a worldwide
development and commercialisation agreement for an antidepressant
with a novel mechanism of action."

"The compound, currently known as EMD 68843 or SB 659746-A, is in
Phase II clinical development."

"It combines the properties of a selective serotonin- reuptake
inhibitor with those of a 5-HT1A partial agonist."


Does anyone know how long it takes for a drug in phase-II trials to be approved?

- Scott

 

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:95939
URL: http://www.dr-bob.org/babble/20020301/msgs/96227.html